Thus leukemia targeting could be achieved by conjugating nanosystems with cell surface markers such as CD19 (in B-cell leukemia) or CD33 (in acute myeloid leukemia) [228]
8 CAS Key Laboratory of Brain Connectome and Manipulation, Brain Cognition and Brain Disease Institute, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
IGF-1 increases 1.5 to 2 times baseline after 1-2 weeks of regular protocol
GLP-1 produces therapeutic effects via synchronized activities within the pancreatic, gastrointestinal, and central neurological systems, making it optimal for the dual control of diabetes and obesity (see to Table 1 for comprehensive mechanisms) (Ruze et al
doi: 10.1136/bjsports-2020-102955 57 OzemekCBonikowskeARChristleJWGalloPM
24 in the Journal of the American Medical Association